Amrutanjan Health Care Limited carries a market capitalization of 15.80B, placing it among publicly traded companies globally. Its enterprise value stands at 12.51B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 15.80B |
| Enterprise Value | 12.51B |
Amrutanjan Health Care Limited currently has 28.90M shares outstanding.
| Shares Outstanding | 28.90M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Amrutanjan Health Care Limited trades at a trailing price-to-earnings ratio of 24.65. The price-to-sales ratio is 2.84, and the price-to-book ratio stands at 493.82.
| PE Ratio | 24.65 |
| PS Ratio | 2.84 |
| PB Ratio | 493.82 |
| P/TBV Ratio | 3.87 |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
On an enterprise value basis, Amrutanjan Health Care Limited trades at an EV/EBITDA multiple of 20.25 and an EV/FCF ratio of 8,625.53. The EV/Sales ratio of 2.49 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 20.25 provides insight into valuation relative to core operating earnings.
| EV / Sales | 2.49 |
| EV / EBITDA | 20.25 |
| EV / EBIT | 20.25 |
| EV / FCF | 8,625.53 |
Amrutanjan Health Care Limited maintains a current ratio of 2.31, meaning it holds 2.3x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 0.48, indicating conservative leverage, while an interest coverage ratio of 316.72 demonstrates strong ability to service its debt obligations.
| Current Ratio | 2.31 |
| Quick Ratio | 1.42 |
| Debt / Equity | 0.48 |
| Debt / EBITDA | 0.03 |
| Interest Coverage | 316.72 |
Amrutanjan Health Care Limited posts a return on equity of 41.56 and a return on invested capital of 13.11.
| Return on Equity (ROE) | 41.56 |
| Return on Assets (ROA) | 12.45 |
| Return on Invested Capital (ROIC) | 13.11 |
| Return on Capital Employed (ROCE) | 41.09 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 7.56 |
Over the trailing twelve months, Amrutanjan Health Care Limited has paid 199.70M in income taxes, reflecting an effective tax rate of 25.64.
| Income Tax | 199.70M |
| Effective Tax Rate | 25.64 |
Amrutanjan Health Care Limited's stock has declined approximately -25.00686% over the past 52 weeks. The 50-day moving average sits at 546.39, while the 200-day moving average is 636.20.
| Beta (5Y) | N/A |
| 52-Week Price Change | -25.00686% |
| 50-Day Moving Average | 546.39 |
| 200-Day Moving Average | 636.20 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Amrutanjan Health Care Limited generated 5.03B in revenue and converted that into 579.18M in net income, yielding earnings per share of 20.03. EBITDA reached 617.61M, while operating income came in at 617.61M.
| Revenue | 5.03B |
| Gross Profit | 2.58B |
| Operating Income | 617.61M |
| Pretax Income | 778.88M |
| Net Income | 579.18M |
| EBITDA | 617.61M |
| EBIT | 617.61M |
| Earnings Per Share (EPS) | 20.03 |
Amrutanjan Health Care Limited holds 1.79B in cash and equivalents against 17.77M in total debt, resulting in a net debt position of -112.72M. Total book value stands at 28.91M, with working capital of 1.65B providing operational flexibility.
| Cash & Cash Equivalents | 1.79B |
| Total Debt | 17.77M |
| Net Debt | -112.72M |
| Equity (Book Value) | 28.91M |
| Book Value Per Share | 1.00 |
| Working Capital | 1.65B |
Amrutanjan Health Care Limited operates with a gross margin of 51.38, reflecting its pricing power and cost economics. The operating margin of 12.29 and net profit margin of 11.52 provide insight into operational efficiency.
| Gross Margin | 51.38 |
| Operating Margin | 12.29 |
| Pretax Margin | 15.50 |
| Profit Margin | 11.52 |
| EBITDA Margin | 12.29 |
Amrutanjan Health Care Limited's most recent stock split took place on April 13, 2018 with a 1:2 split ratio.
| Last Split Date | 4/13/2018 |
| Split Ratio | 1:2 |
Amrutanjan Health Care Limited posts an Altman Z-Score of 7.96, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 7.96 |